IMUX - Immunic - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMUX is currently covered by 1 analysts with an average price target of $6.25. This is a potential upside of $19.89 (-62.01%) from yesterday's end of day stock price of $16.45.

Immunic's activity chart (see below) currently has 4 price targets and 4 ratings on display. The stock rating distribution of IMUX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 6.15% with an average time for these price targets to be met of 32.62 days.

Highest price target for IMUX is $8, Lowest price target is $4, average price target is $6.25.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 02-Mar-2026. First documented stock forecast 11-May-2020.

Currently out of the existing stock ratings of IMUX, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Sep-2022

$8

$-7.3 (-47.71%)

$10

Buy Since 31-Jan-2023

$5

$3.83 (327.35%)

$5

Show more analysts

Please expand the browser size to see the chart

What is IMUX (Immunic) average time for price targets to be met?

On average it took 32.62 days on average for the stock forecasts to be realized with a an average price target met ratio 6.15

Which analyst has the current highest performing score on IMUX (Immunic) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on IMUX (Immunic)?

Andrew Fein works at HC WAINWRIGHT and has 30 price targets and 26 ratings on IMUX

Which analyst is the currently most bullish on IMUX (Immunic)?

George Farmer with highest potential upside - $59.83

Which analyst is the currently most reserved on IMUX (Immunic)?

Andrew Fein with lowest potential downside - -$8.06

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?